The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

BACKGROUND AND PURPOSE: Atypical cannabinoids are thought to cause vasodilatation through an as-yet unidentified ‘CBx' receptor. Recent reports suggest GPR55 is an atypical cannabinoid receptor, making it a candidate for the vasodilator ‘CBx' receptor. The purpose of the present study was...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Johns, D G, Behm, D J, Walker, D J, Ao, Z, Shapland, E M, Daniels, D A, Riddick, M, Dowell, S, Staton, P C, Green, P, Shabon, U, Bao, W, Aiyar, N, Yue, T-L, Brown, A J, Morrison, A D, Douglas, S A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2007
Gaiak:
Research Papers
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2190033/
https://ncbi.nlm.nih.gov/pubmed/17704827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707419
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak